ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658371 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658371; 2) Community: the network communities that were significantly associated with the response to NSC 658371; 3) Molecule: the relationships between components within communities and NSC 658371; 4) MDR: the compounds that were significantly associated with the NSC 658371.

NSC Compound Enrichment Correlation
NSC 622297 Null 0.00216534295403404 0.54346792
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.00216534295403404 0.29788722
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.00216534295403404 -0.13212437
NSC 631136 Benzoxazole, 2-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]- 0.00216534295403404 0.31690103
NSC 639501 Cyclopentanone, 2-pentylidene-5-[(1-piperidinyl)methyl]- hydrochloride 0.00216534295403404 0.21085828
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.00216534295403404 0.30743907
NSC 639541 Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- 0.00216534295403404 0.43552732
NSC 681641 Camptothecin Derivative 0.00216534295403404 0.17953257
NSC 132279 Null 0.00228818143845077 0.24338926
NSC 155594 Null 0.00228818143845077 0.37001705
Total:166  Current:28    [First] [Prev] [Next] [Last]